Quris is an artificial intelligence innovator that is disrupting the drug development process.Quris's Bio-AI Clinical Prediction Platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials.They are led by a team of top scientists and strategic investors and are actively preparing for clinical testing with our first AI-based drug.
Quris’s unique machine-learning approach using the Bio-AI Clinical Prediction Platform is radically different: By using a patented process to test known safe and unsafe drugs on miniaturized Patients-on-a-Chip with their automated, high-throughput system, data is generated, classified, and continuously re-trains the machine learning algorithm which is highly predictive of clinical safety and efficacy.
Total Funding: $28 M
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2019
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Quris Technologies
